Select Publications

Journal articles

Markus R; Brew BJ; Turner J; Pell MF, 1997, 'Successful outcome with aggressive treatment of acute haemorrhagic leukoencephalitis', Journal of Neurology Neurosurgery and Psychiatry, pp. 551 - 551

Dunbar N; Brew B, 1996, 'Neuropsychological dysfunction in HIV infection: A review', Journal of Neuro-AIDS, 1, pp. 73 - 102, http://dx.doi.org/10.1300/J128v01n03_05

Brew BJ; Glass JD; McArthur JC, 1996, 'Human immunodeficiency virus in brain and correlation with dementia [5]', Annals of Neurology, 39, pp. 828 - 829, http://dx.doi.org/10.1002/ana.410390631

Wright EJ; Brew BJ; Currie JN; McArthur JC, 1996, '5.4 HIV-induced neurological disease', Medical Journal of Australia, 164, pp. 414 - 417, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122090.x

Jones PD; Beaman MH; Brew BJ, 1996, '5.5 HIV and opportunistic neurological infections', Medical Journal of Australia, 164, pp. 418 - 421, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122091.x

Jones PD; Beaman MH; Brew BJ, 1996, 'Managing HIV .5. Treating secondary outcomes - HIV and opportunistic neurological infections', MEDICAL JOURNAL OF AUSTRALIA, 164, pp. 418 - 421, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122091.x

Wright EJ; Brew BJ; Currie JN; McArthur JC, 1996, 'Managing HIV .5. Treating secondary outcomes - HIV-induced neurological disease', MEDICAL JOURNAL OF AUSTRALIA, 164, pp. 414 - 417, http://dx.doi.org/10.5694/j.1326-5377.1996.tb122090.x

Brew BJ; Wesselingh SL; Gonzales M; Heyes MP; Price RW, 1996, 'How HIV leads to neurological disease', Medical Journal of Australia, 164, pp. 233 - 234, http://dx.doi.org/10.5694/j.1326-5377.1996.tb94148.x

Brew BJ; Wesselingh SL; Gonzales M; Heyes MP; Price RW, 1996, 'Managing HIV. Part 3: Mechanisms of diseases. 3.7 How HIV leads to neurological disease.', Med J Aust, 164, pp. 233 - 234, https://www.ncbi.nlm.nih.gov/pubmed/8604196

Norton GR; Sweeney J; Marriott D; Law MG; Brew BJ, 1996, 'Association between HIV distal symmetric polyneuropathy and Mycobacterium avium complex infection', Journal of Neurology Neurosurgery and Psychiatry, 61, pp. 606 - 609, http://dx.doi.org/10.1136/jnnp.61.6.606

Norton GR; Sweeney J; Marriott D; Law MG; Brew BJ, 1996, 'An association between HIV distal symmetrical polyneuropathy and Mycobacterium Avium complex infection', Journal of Neurology Neurosurgery and Psychiatry, pp. 606 - 609

Brew BJ; Miller J, 1996, 'Human immunodeficiency virus type 1 related transient neurologic deficits', American Journal of Medicine, 101, pp. 257 - 261

Field AS; Marriot DJ; Milliken ST; Brew BJ; Canning EU; Kench JG; Darveniza P; Harkness JL, 1996, 'Myositis associated with a newly describes microsporidian Trachipleistophora hominis, in a patient with AIDS', Journal of Clinical Microbiology, pp. 2803 - 2811

Kerr SJ; Armati P; Brew BJ, 1996, 'Neurocytotoxicity of quinolinic acid in human brain cultures', Journal of Neurovirology, 1, pp. 375 - 380

Brew BJ; Dunbar N; Druett J; Freund J; Ward PB, 1996, 'Pilot study of the efficacy of atervidine in ADC', AIDS, 10, pp. 1357 - 1360

Brew BJ; Dunbar N; Druett J; Freund J; Ward PB, 1996, 'Pilot study of the efficacy of atevirdine in the treatment of AIDS dementia complex', AIDS, 10, pp. 1357 - 1360

Brew BJ; Corbeil J; Pemberton LA; Evans L; Saito K; Penny R; Cooper DA; Heyes MP, 1996, 'Quinolinic acid production by macrophages infected with HIV-1 isolates from patients with and without AIDS dementia complex', Journal of Neurovirology, 1, pp. 369 - 374

Brew BJ; Evans L; Byrne C; Pemberton LA; Hurren L, 1996, 'The relationship between AIDS demtia complex and the presence of macriphage tropic and non syncytium inducing isolates of human immunodeficiency virus type 1 in the cerebrospinal fluid', Journal of Neurovirology, 2, pp. 152 - 157

Brew BJ; Rosenblum M; Cronin K; Price RW, 1995, 'AIDS dementia complex and HIV‐1 brain infection: Clinical‐virological correlations', Annals of Neurology, 38, pp. 563 - 570, http://dx.doi.org/10.1002/ana.410380404

Brew BJ; Corbeil J; Pemberton L; Evans L; Saito K; Penny R; Cooper DA; Heyes MP, 1995, 'Quinolinic acid production is related to macrophage tropic isolates of HIV-1.', Journal of neurovirology, 1, pp. 369 - 374, http://dx.doi.org/10.3109/13550289509111026

Davies MA; Pell MF; Brew BJ, 1995, 'Stereotactic biopsy of cerebral lesions in acquired immunodeficiency syndrome', Journal of Clinical Neuroscience, 2, pp. 40 - 44, http://dx.doi.org/10.1016/0967-5868(95)90028-4

Dick AD; Pell M; Brew BJ; Sedgwick JD, 1995, 'Flow cytometric phenotyping of freshly isolated, human CNS microglia reveals increased CD4 expression in HIV-infected individuals', Journal of Neuroimmunology, 63, pp. 99 - 99, http://dx.doi.org/10.1016/0165-5728(96)80983-0

Davies MJ; Pell MF; Brew BJ, 1995, 'Stereotactic biopsy of cerebral lesions in AIDS', Journal of Clinical Neuroscience, 2, pp. 40 - 44

Davies MJ; Pell MF; Brew BJ, 1995, 'Stereotectic biopsy of cerebral lesions in AIDS', Journal of Clinical Neuroscience, 2, pp. 40 - 44

Brew BJ; Rosenblum M; Cronin K; Price R, 1995, 'The AIDS dementia complex and human immunodeficiency virus type 1 brian infection: clinical-virological correlations', Annals of Neurology, pp. 563 - 570

Brew BJ; Paul MO; Nakajima G; Khan A; Gallardo H; Price RW, 1994, 'Cerebrospinal fluid HIV-1 p24 antigen and culture: Sensitivity and specificity for AIDS-dementia complex', Journal of Neurology, Neurosurgery and Psychiatry, 57, pp. 784 - 789, http://dx.doi.org/10.1136/jnnp.57.7.784

Milstien S; Sakai N; Brew BJ; Krieger C; Vickers JH; Saito K; Heyes MP, 1994, 'Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases', Journal of Neurochemistry, 63, pp. 1178 - 1180, http://dx.doi.org/10.1046/j.1471-4159.1994.63031178.x

Brew BJ, 1994, 'HIV dementia', Neurology, 44, pp. 2214, http://dx.doi.org/10.1212/wnl.44.11.2214-a

Kelleher AD; Brew BJ; Milliken ST, 1994, 'Intractable headache as the presenting complaint of AIDS-related lymphoma confined to bone', Journal of Acquired Immune Deficiency Syndromes, 7, pp. 629 - 630

Clezy K; Sirisanthana T; Sirisanthana V; Brew B; Cooper DA, 1994, 'Late manifestations of HIV in Asia and the Pacific', AIDS, 8

Brew BJ, 1994, 'Optimal Treatment of HIV-1-Induced CNS Neurological Disorders', CNS Drugs, 2, pp. 292 - 300, http://dx.doi.org/10.2165/00023210-199402040-00005

Brew BJ, 1994, 'The clinical spectrum and pathogenesis of HIV encephalopathy, myelopathy, and peripheral neuropathy', Current Opinion in Neurology, 7, pp. 209 - 216, http://dx.doi.org/10.1097/00019052-199406000-00006

Brew B, 1994, 'HIV, AIDS and the brain', Journal of Clinical Neuroscience, 1, pp. 213 - 214, http://dx.doi.org/10.1016/0967-5868(94)90056-6

Quinn D; Pocock N; Freund J; Kelleher A; Penny R; Brew B, 1993, 'Radionuclide hepatobiliary scanning in patients with AIDS-related sclerosing cholangitis', Clinical Nuclear Medicine, 18, pp. 417 - 422, http://dx.doi.org/10.1097/00003072-199305000-00010

BREW BJ; CURRIE JN, 1993, 'COULD IT BE HIV .8. HIV-RELATED NEUROLOGICAL DISEASE', MEDICAL JOURNAL OF AUSTRALIA, 158, pp. 104 - 108, http://dx.doi.org/10.5694/j.1326-5377.1993.tb137536.x

Brew BJ; Currie JN, 1993, 'HIV-related neurological disease', Medical Journal of Australia, 158, pp. 104 - 108, http://dx.doi.org/10.5694/j.1326-5377.1993.tb137536.x

Brew BJ; Miller J, 1993, 'Human immunodeficiency virus-related headache', Neurology, 43, pp. 1098 - 1100

Brew BJ, 1993, 'The pathogenesis of the neurological complications of HIV-1 infection', Genitourinary Medicine, 69, pp. 333 - 340, http://dx.doi.org/10.1136/sti.69.5.333

Carr A; Tindall B; Brew BJ; Marriott DJ; Harkness JL; Penny R; Cooper DA, 1992, 'Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS', Annals of Internal Medicine, 117, pp. 106 - 111

Brew BJ, 1992, 'Central and peripheral nervous system abnormalities', Medical Clinics of North America, 76, pp. 63 - 81, http://dx.doi.org/10.1016/S0025-7125(16)30371-6

Brew BJ; Bhalla RB; Paul M; Sidtis JJ; Keilp JJ; Sadler AE; Gallardo H; McArthur JC; Schwartz MK; Price RW, 1992, 'Cerebrospinal fluid β2-microglobulin in patients with AIDS dementia complex: An expanded series including response to zidovudine treatment', AIDS, 6, pp. 461 - 465

Brew BJ; Perdices M, 1992, 'HIV nomenclature', Neurology, 42, pp. 265, http://dx.doi.org/10.1212/WNL.42.1.265

Rosenblum MK; Brew BJ; Hahn B; Shaw G; Haase A; Maroushek S; Price RW, 1992, 'Human T-lymphotropic virus type I-associated myelopathy in patients with the acquired immunodeficiency syndrome', Human Pathology, 23, pp. 513 - 519, http://dx.doi.org/10.1016/0046-8177(92)90128-P

Shaskan EG; Brew BJ; Rosenblum M; Thompson RM; Price RW, 1992, 'Increased Neopterin Levels in Brains of Patients with Human Immunodeficiency Virus Type 1 Infection', Journal of Neurochemistry, 59, pp. 1541 - 1546, http://dx.doi.org/10.1111/j.1471-4159.1992.tb08471.x

Heyes MP; Brew BJ; Saito K; Quearry BJ; Price RW; Lee K; Bhalla RB; Der M; Markey SP, 1992, 'Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and β2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients', Journal of Neuroimmunology, 40, pp. 71 - 80, http://dx.doi.org/10.1016/0165-5728(92)90214-6

Brew BJ, 1992, 'Medical management of AIDS patients. Central and peripheral nervous system abnormalities.', Med Clin North Am, 76, pp. 63 - 81, http://dx.doi.org/10.1016/s0025-7125(16)30371-6

Reimund E; Martin AA; Emerich DF; Sanberg PR; James Brew B; Everall I; Luthert P; Lantos P, 1991, 'Neuronal loss in frontal cortex in HIV infection', The Lancet, 338, pp. 129 - 130, http://dx.doi.org/10.1016/0140-6736(91)90131-8

KAPLAN JE; LITCHFIELD B; ROUAULT C; LAIRMORE MD; LUO CC; WILLIAMS L; BREW BJ; PRICE RW; JANSSEN R; STONEBURNER R; OU CY; FOLKS T; DE B, 1991, 'HTLV-I ASSOCIATED MYELOPATHY ASSOCIATED WITH BLOOD-TRANSFUSION IN THE UNITED-STATES - EPIDEMIOLOGIC AND MOLECULAR EVIDENCE LINKING DONOR AND RECIPIENT', NEUROLOGY, 41, pp. 192 - 197, http://dx.doi.org/10.1212/WNL.41.2_Part_1.192

Price RW; Sidtis JJ; Brew BJ, 1991, 'AIDS Dementia Complex and HIV‐1 Infection: A View From the Clinic', Brain Pathology, 1, pp. 155 - 162, http://dx.doi.org/10.1111/j.1750-3639.1991.tb00655.x

Heyes MP; Brew B; Martin A; Markey SP; Price RW; Bhalla RB; Salazar A, 1991, 'Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome', Advances in Experimental Medicine and Biology, 294, pp. 687 - 690, http://dx.doi.org/10.1007/978-1-4684-5952-4_94


Back to profile page